Doctor profile · Federal record

Dr. Yasolatha Nalamolu, MD

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Medical Oncology Physician · Fort Wayne, IN

  • NPI 1831173269
  • Accepts Medicare
  • MIPS 87.0 / 100 · 2023
  • 29 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
7910 W Jefferson Blvd Ste 108
Fort Wayne, IN 468044159
(260) 484-8830
fax (260) 483-1911
Mailing address
Po Box 749495
Atlanta, GA 303749495

Credentials & registration

NPPES · NUCC
NPI registered
November 2005 — 21 yrs on file
Profile last updated
May 15, 2025
Year of graduation
1997 — 29 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
Indiana #01061156A
Medicaid (2)
IN #200803130 · OH #3045467

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1831173269. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
33,893
Distinct HCPCS
10
Medicare allowed
$727,697
HCPCS Description Services Patients Avg allowed
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 12,750 23 $0
J9271 Injection, pembrolizumab, 1 mg 7,800 12 $54
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 4,900 41 $0
J9267 Injection, paclitaxel, 1 mg 2,433 12 $0
J0897 Injection, denosumab, 1 mg 2,040 18 $23
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,162 50 $0
99214 Established patient office or other outpatient visit, 30-39 minutes 591 247 $119
J2469 Injection, palonosetron hcl, 25 mcg 320 19 $1
96375 Injection of additional new drug or substance into vein 219 57 $14
96413 Administration of chemotherapy into vein, 1 hour or less 181 69 $118

In context: peer comparison

Among 11 peers in this city , average services per provider: 763. This provider delivers 44× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$5,749
Transactions
39
Manufacturers
12
Payer (manufacturer) Industry Txns Amount
Daiichi Sankyo Inc. 5 $3,461.25
Novartis Pharmaceuticals Corporation 10 $884.17
Cornerstone Specialty Network LLC 1 $550.00
E.R. Squibb & Sons, L.L.C. 6 $340.09
Janssen Biotech, Inc. 2 $176.52
Boston Scientific Corporation 1 $99.05
Merck Sharp & Dohme LLC 5 $85.84
PFIZER INC. 3 $44.52
Adaptive Biotechnologies Corporation 2 $36.42
ABBVIE INC. 2 $31.32
Ipsen Biopharmaceuticals, Inc 1 $22.68
Coherus Biosciences Inc. 1 $16.90

By nature of payment

Consulting Fee
$3,461
Long term medical supply or device loan
$881
Food and Beverage
$701
Honoraria
$550
Travel and Lodging
$155

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
558
Patients
116
Total drug cost
$713,019
Drug Type Claims Patients Total cost
Anastrozole Generic 200 57 $12,815
Letrozole Generic 56 18 $1,930
Acyclovir Generic 53 0 $1,141
Dexamethasone Generic 39 13 $430
Eliquis (Apixaban) Brand 39 12 $40,181
Tamoxifen Citrate Generic 24 0 $1,289
Lidocaine-Prilocaine (Lidocaine/Prilocaine) Brand 20 16 $330
Xarelto (Rivaroxaban) Brand 20 0 $16,957
Pomalyst (Pomalidomide) Brand 19 0 $416,629
Exemestane Generic 18 0 $4,233

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Yasolatha Nalamolu's medical specialty?
Dr. Yasolatha Nalamolu practices Hematology & Oncology Physician in Fort Wayne, IN.
Where does Dr. Yasolatha Nalamolu practice?
Dr. Yasolatha Nalamolu practices at 7910 W Jefferson Blvd Ste 108, Fort Wayne, IN 468044159. Office phone: 2604848830.
What is Dr. Yasolatha Nalamolu's NPI?
Dr. Yasolatha Nalamolu's National Provider Identifier (NPI) is 1831173269, issued by NPPES.
Does Dr. Yasolatha Nalamolu accept Medicare assignment?
Yes. Dr. Yasolatha Nalamolu accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Yasolatha Nalamolu commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, pembrolizumab, 1 mg (HCPCS J9271); Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS Q9967). Source: CMS Medicare Physician & Other Practitioners file.